ANNALS OF NEUROLOGY

Scope & Guideline

Leading the Charge in Neurological Advancements

Introduction

Explore the comprehensive scope of ANNALS OF NEUROLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ANNALS OF NEUROLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0364-5134
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1977 to 2024
AbbreviationANN NEUROL / Ann. Neurol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The Annals of Neurology is dedicated to publishing high-quality research that advances the understanding and treatment of neurological disorders. The journal encompasses a broad range of topics within neurology, including clinical practice, translational research, and basic neuroscience. Key areas of focus include neurodegenerative diseases, cerebrovascular diseases, neuroinflammation, and genetic disorders.
  1. Clinical Neuroscience:
    Research focusing on the diagnosis, treatment, and management of neurological conditions, including stroke, epilepsy, and neurodegenerative diseases.
  2. Neurogenetics:
    Studies investigating the genetic basis of neurological disorders, including the identification of genetic mutations and their implications for disease mechanisms and treatment.
  3. Neuroimmunology:
    Research on the interactions between the nervous system and the immune system, particularly in autoimmune neurological disorders such as multiple sclerosis and neuromyelitis optica.
  4. Neuropharmacology and Therapeutics:
    Investigations into the pharmacological treatments for neurological conditions, including clinical trials of new therapies and their mechanisms of action.
  5. Neuroinflammation:
    Studies examining the role of inflammation in neurological diseases, including the impact of cytokines and immune responses on neurodegeneration and recovery.
  6. Neuroimaging:
    Research utilizing advanced imaging techniques to understand brain structure and function in health and disease, including MRI and PET studies.
  7. Pediatric Neurology:
    Focused research on neurological disorders affecting children, including congenital conditions, epilepsy syndromes, and neurodevelopmental disorders.
In recent years, the Annals of Neurology has seen a rise in research themes that address contemporary challenges in neurology, particularly those influenced by technological advancements and the ongoing impact of global health issues. These emerging themes reflect the journal's responsiveness to current trends and the evolving landscape of neurological research.
  1. Telemedicine and Remote Care:
    The COVID-19 pandemic has accelerated the adoption of telemedicine in neurology, leading to increased research on its effectiveness, accessibility, and patient outcomes.
  2. Neuroinflammation and Immune Responses:
    Research exploring the role of neuroinflammation in various neurological disorders is gaining momentum, particularly in understanding how immune responses affect neurodegenerative diseases.
  3. Biomarker Discovery and Precision Medicine:
    There is a growing emphasis on identifying biomarkers for neurological diseases to enable precision medicine approaches, tailoring treatments based on individual patient profiles.
  4. Neurotechnologies and Machine Learning:
    Innovations in neurotechnology and machine learning applications are increasingly being explored for improving diagnostic accuracy, treatment efficacy, and patient monitoring.
  5. Long COVID and Neurological Sequelae:
    Research focusing on the long-term neurological effects of COVID-19 has emerged as a significant area of interest, addressing a pressing public health concern.
  6. Genetic and Molecular Mechanisms:
    Investigations into the genetic underpinnings of neurological diseases, including rare genetic disorders, are gaining traction, aligning with advances in genomic technologies.

Declining or Waning

While the journal has consistently published research across various domains of neurology, some themes have shown signs of declining interest or publication frequency in recent years. This may reflect shifting research priorities or advances in methodology that have made certain topics less prominent.
  1. Traditional Neurology Education:
    There is a noticeable shift away from traditional educational approaches in neurology towards more innovative, technology-driven learning methods, reflecting the evolving landscape of medical education.
  2. Basic Neuroscience:
    Research focusing solely on basic neuroscience without direct clinical applications has seen a decline in favor of studies that bridge basic science with clinical practice and translational research.
  3. Single-Center Studies:
    There has been a reduction in the publication of single-center studies as there is a growing emphasis on multicenter collaborations and larger cohort studies to enhance generalizability.
  4. Descriptive Studies:
    Descriptive studies that lack rigorous methodological frameworks are being published less frequently, as there is a greater focus on hypothesis-driven research with robust statistical analyses.

Similar Journals

LANCET NEUROLOGY

Exploring Breakthroughs in Neurological Disorders
Publisher: ELSEVIER SCIENCE INCISSN: 1474-4422Frequency: 12 issues/year

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Nurturing the Future of Neurological Science
Publisher: CAMBRIDGE UNIV PRESSISSN: 0317-1671Frequency: 6 issues/year

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

ACTA NEUROLOGICA BELGICA

Elevating Clinical Practice Through Rigorous Research.
Publisher: SPRINGER HEIDELBERGISSN: 0300-9009Frequency: 4 issues/year

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

Neurosciences

Unveiling new perspectives in the study of the mind and brain.
Publisher: RIYADH ARMED FORCES HOSPITALISSN: 1319-6138Frequency: 4 issues/year

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

INTERNATIONAL JOURNAL OF NEUROSCIENCE

Advancing the Frontiers of Neuroscience Knowledge
Publisher: TAYLOR & FRANCIS LTDISSN: 0020-7454Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF NEUROSCIENCE, published by TAYLOR & FRANCIS LTD, stands as a vital resource in the field of neuroscience since its inception. With a proud history of publication from 1970 to 2024, this journal is committed to advancing knowledge in various domains of neuroscience, from fundamental research to clinical applications. It is indexed with an ISSN of 0020-7454 and an E-ISSN of 1563-5279, reflecting its wide reach and recognition. The journal maintains a respectable position in the academic landscape, categorized as Q2 in Medicine (miscellaneous) and Q3 in Neuroscience (miscellaneous) as of 2023, signifying its relevance among researchers and professionals. Although it currently does not offer open access, the journal remains a significant platform for disseminating groundbreaking research, thereby fostering collaboration and innovation within the neuroscience community. Located in the United Kingdom, the journal aims to bridge gaps in neuroscience knowledge, making it an essential reading for students, professionals, and researchers dedicated to unraveling the complexities of the nervous system.

NEUROLOGICAL SCIENCES

Connecting minds to enhance patient outcomes in neurology.
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1590-1874Frequency: 12 issues/year

NEUROLOGICAL SCIENCES, published by SPRINGER-VERLAG ITALIA SRL, is a premier journal that has been a cornerstone in the field of neurology and related disciplines since its inception in 1996. With an impressive Q1 ranking in Dermatology and Q2 rankings in Neuroloy (clinical) as well as Psychiatry and Mental Health, this journal consistently delivers high-quality peer-reviewed research that informs and shapes clinical practice. The journal boasts a significant presence on Scopus, positioned in the 89th percentile for Dermatology, 73rd for Psychiatry and Mental Health, and 72nd for Neurology (clinical), reflecting its influential contributions to medical knowledge. Open Access options are available, ensuring that this valuable research is accessible to a wider audience committed to advancing their understanding of neurological sciences. As it converges into future years (2024 and beyond), NEUROLOGICAL SCIENCES aims to continue foster collaboration and innovation amongst researchers, professionals, and students within the neurology and mental health domains, making it an indispensable resource for those dedicated to improving patient outcomes and advancing scholarly dialogue.

JOURNAL OF THE NEUROLOGICAL SCIENCES

Elevating the discourse in neurological and clinical sciences.
Publisher: ELSEVIERISSN: 0022-510XFrequency: 12 issues/year

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.

CORTEX

Unveiling Insights into Cognitive Processes
Publisher: ELSEVIER MASSON, CORP OFFISSN: 0010-9452Frequency: 10 issues/year

CORTEX is a premier international journal published by Elsevier Masson, focusing on the cutting-edge areas of cognitive neuroscience, psychology, and neurology. With an impressive impact factor that places it in Q1 quartiles across multiple categories such as Cognitive Neuroscience and Neuropsychology, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 1964, CORTEX has continued to excel in disseminating high-quality scholarly work, offering insights that significantly enhance our understanding of the brain's functioning and behavior. Although not an open-access publication, it provides various access options to ensure the dissemination of knowledge is as wide-reaching as possible. As the field of cognitive psychology evolves, CORTEX remains at the forefront, fostering an environment for interdisciplinary collaboration and innovation. Researchers seeking to stay engaged with the latest advancements will find CORTEX an indispensable tool for their professional development.

Neurology International

Empowering Knowledge in Neurological Disorders
Publisher: MDPIISSN: 2035-8377Frequency: 4 issues/year

Neurology International is a prestigious open-access journal published by MDPI that has been making significant contributions to the field of neurology since its establishment in 2009. With its ISSN 2035-8377, this journal is committed to disseminating high-quality, peer-reviewed research that addresses a wide range of clinical topics in neurology. Operating out of Basel, Switzerland, the journal holds a respectable Q2 ranking in the clinical neurology category as of 2023, indicating its influence and dedication to advancing scientific knowledge. Researchers and practitioners alike will find value in its comprehensive articles, which are readily accessible to a global audience, facilitating the sharing of innovative findings and clinical practices. As it converges towards 2024, Neurology International continues to provide a vital platform for scholarly discourse, aiming to improve patient outcomes and enhance our understanding of neurological disorders.

NEUROLOGICAL RESEARCH

Connecting Researchers to the Heart of Neurology
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.